Filtered By:
Source: Current Drug Safety

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 40 results found since Jan 2013.

Thrombolytic Treatment of Cardiac Myxoma-Induced Ischemic Stroke: a Review.
Abstract Primary cardiac tumors are uncommon, with an autopsy frequency of 0.001%-0.28%: 75% of them are benign, and 50-75% of these are myxomas. Often the first neurological manifestations of a cardiac myxoma include transient ischemic attacks and ischemic strokes. Although thrombolytic therapy represents the gold standard for acute ischemic stroke treatment, its safety and effectiveness in stroke patients with myxoma is unknown. From the analysis of the literature on thrombolysis in ischemic stroke patients with myxoma we report clinical evidence supporting the use of thrombolytics, and the application of thromb...
Source: Current Drug Safety - January 10, 2014 Category: Drugs & Pharmacology Authors: Acampa M, Guideri F, Tassi R, D'Andrea P, Marotta G, Giudice GL, Martini G Tags: Curr Drug Saf Source Type: research

Management of acute stroke among Lebanese patients: Assessing adherence to international guidelines
CONCLUSIONS: The study highlights that guideline recommendations was not uniformly applied among all patients, and that recommendation standards set by the guidelines were not applied among all hospitals.PMID:36411559 | DOI:10.2174/1574886318666221118151504
Source: Current Drug Safety - November 22, 2022 Category: Drugs & Pharmacology Authors: Diana Malaeb Sarah Cherri Iqbal Fahs Hala Sacre Emane Abdallah Pascale Salameh Hassan Hosseini Source Type: research

Isolated tongue angioedema after alteplase infusion in acute ischemic stroke
CONCLUSION: Although the incidence of alteplase-induced angiodema in these patients is rare, this case report suggests the need for routine inspection of the tongue in acute ischemic patient in treatment with alteplase infusion, especially in female patients in treatment with ACE inhibitors.PMID:34323196 | DOI:10.2174/1574886316666210728104331
Source: Current Drug Safety - July 29, 2021 Category: Drugs & Pharmacology Authors: Ermanno Pisani Carmen Gaudiano Alfredo Petrone Furio Stancati Antonio Siniscalchi Source Type: research